Sponsor Pipeline

InSilico Medicine Hong Kong Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
6
Recruiting
1
Phase 3
4
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-24 NCT06724042
Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors
date change Primary completion pushed: 2029-06-30 -> 2029-12-30
2026-07-24 NCT06724042
Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors
date change Completion pushed: 2030-06-30 -> 2030-12-30
Active Trials by Phase
Phase 3
1
Phase 2
2
Phase 1/2
1
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07687459 Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic… Idiopathic Pulmonary Fibrosis Not Yet Recruiting
Phase 2
NCT05975983 Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary… Idiopathic Pulmonary Fibrosis (IPF) Recruiting
NCT07265570 Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis… Ulcerative Colitis Recruiting
Phase 1/2
NCT06414460 Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors Locally Advanced/Metastatic Solid Tumors Recruiting
Phase 1
NCT06566079 Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other… Malignant Mesothelioma Recruiting
NCT07581431 A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of… Healthy Subjects (HS) Recruiting
NCT06445517 Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and… Advanced Solid Tumors Recruiting
NCT06724042 Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors Advanced Solid Tumor Not Yet Recruiting
Disease Areas
Get alerts when InSilico Medicine Hong Kong Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free